Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
sales of 8.34 million Australian Dollars [US$5.91 million]
of which 100%
was Clinical development),
AFT Pharmaceuticals Ltd
of NEW ZEALAND
(105.60 million New Zealand Dollars [US$69.75 million]
of which 58%
was Australia), and
Blis Technologies Ltd
based in NEW ZEALAND
(10.64 million New Zealand Dollars [US$7.03 million]
Probiotec Limited reported sales of A$107.22 million (US$75.94 million)
June of 2020.
increase of 35.6%
versus 2019, when the company's sales were A$79.09 million.
This was the third consecutive year of growth at Probiotec Limited.